This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
New Christmas Quiz Champion Crowned
February 15, 2019
National and European Centre of Excellence in Medical Mycology
February 15, 2019
COPD – getting the best out of treatments
February 15, 2019
EU debate on biosimilar drugs
February 15, 2019
Number of People in UK With Fungal Disease Rises
February 15, 2019
Medicine for the Mind
February 15, 2019
Assistance for Patients Who Cannot Afford Antifungal Drugs (US only)
February 15, 2019
How do I know that this research paper is any good?
February 15, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video